Medicare Advantage Companies’ Lofty Valuations Draw Skepticism

Home health, home care and hospice M&A activity was down on a year-over-year basis, though private equity investors and strategic buyers remain optimistic that the market will level itself out.

There’s a push and pull that exists in PE firm-agency relationships. It’s up to both sides to agree on a long-term strategy and to have an open dialogue throughout the process, before and after an investment.

Startups in the reproductive healthcare space face yet another battle: fundraising in 2023's tough dealmaking environment, just as the legal landscape for abortion care shifts under their feet.

After a hot start to the year on the heels of a booming end to 2021, the volume of announced and closed deals in the health-care and life science markets has notched a little lower in the first quarter.